TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Patients with Microbiologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total number of practicing incentive spirometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Treatment-emergent Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: pro-inflammatory cytokines levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Cocaine Negative Urines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total attitudes scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: total practices scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Medical Sequelae in COVID-19 Survivors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental health status in COVID-19 survivors and contacts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of reinfection with COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: vascular sensitivity (ED50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: response (Emax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Overall Survival Rate at 3 Years
Endpoint domain: Mortality/survival
Primary endpoint: Quality of Life as Measured by the Functional Assessment of Cancer Therapy Scale With Brain Module (FACT-BR)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Birth defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Spontaneous fetal losses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: n-3 serum alpha-linoleic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Participants With Hepatitis B e Antigen (HBeAg) Loss & HBV DNA Levels ≤1,000 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Adverse Events (AEs) Per Person-Year
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Serious Adverse Events (SAEs) Per Person-Year
Endpoint domain: Adverse events/effects
Primary endpoint: Congruence with gestational weight gain guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in diaphragm position and morphology on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: IOP Fluctuation Pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Respiratory disturbance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Neurocognitive Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants with Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Artery plaque composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of intake of food groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participants with Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: SpO2 accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to ipsilateral recurrence
Endpoint domain: Mortality/survival
Primary endpoint: SVR (Sustained Virologic Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acute Change in Flow mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Chronic Change in Flow mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute Change in exercise capacity (VO2 peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Chronic Change in exercise capacity (VO2 peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence and severity of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Use of healthcare services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Suicide
Endpoint domain: Mortality/survival
Primary endpoint: Maximal tolerated dose (MTD)
Endpoint domain: Adverse events/effects
Primary endpoint: Dose limiting Toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Fitzpatrick Wrinkle Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change score in Trail Making Test A & B
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in total Hair Count at 1 month post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total Hair Count at 3 months post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline depressive symptom at week 10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline pain at week 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline fatigue at week 10
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline sleep disturbance at week 10
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline perceived stress at week 10
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported Serious Quit Attempt
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Self-reported Treatment Seeking
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adult subjective assessment of participation (ASAP)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Work Behavior Inventory (WBI)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Work self efficacy Questionnaire (WSS-37)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in the Mini-Mental State Examination (MMSE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: changes in the cognitive subscale of the AD Assessment Scale (ADAS-cog)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Loose/Unformed/Liquid Stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Abdominal Cramping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Resting state brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Erectile Function Domain Score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Number of Facial Actinic Keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Detection of poliovirus, enteric pathogens and antimicrobial resistance genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reflux Symptom Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Freedom From Aneurysm Rupture
Endpoint domain: Mortality/survival
Primary endpoint: Status of relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enzymes involved in fatty acid oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: enzymes involved in oxidative phosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: enzymes involved in glycolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of days to adequate stem cell harvest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking abstinence in late pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sequelae after COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to Bronchodilators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Inappropriate Medication at Follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Dose-limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in Psoriasis Area and Severity Score (PASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in Investigator Grade Assessment (IGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in Body Surface Area (BSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Presence and severity of periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Immune response in the oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Microbiome characterization in the oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P38 MAPK activation (phosphorylation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of severity of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic change in the primary tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Radiographic change in the primary largest pathologic lymph node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in symptoms associated with diabetic gastroparesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Cocaine Non-use Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of Participants With New Use
Endpoint domain: Adverse events/effects
Primary endpoint: Clavien-Dindo grade for postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of end-stage renal disease or all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Fluorescein performance as an intraoperative biomarker for tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Interpersonal Violence Victimization and Perpetration
Endpoint domain: Adverse events/effects
Primary endpoint: Total fentanyl consumption during 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Clinical Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant engagement in decision making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximal voluntary muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Alexithymia rate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean percent change in lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of participants staying abstinent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quantitative Prehension Ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change of Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Community Balance and Mobility Scale (CB & M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in colonization status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of recurrent SSTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in morning blood pressure surge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in central systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in central diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in central pulse pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in augmentation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change of Victorian Institute of Sports Assessment-Achilles score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change of American Orthopaedic Foot & Ankle Society score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of Tegner score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ventilatory stability by frequency of central apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ventilatory stability by frequency of obstructive apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ventilatory stability by density of periodic breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ventilatory stability by time series of inter-breath intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acute autonomic stress responsivity (heart rate, HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute HPA axis stress responsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of virtopsy made completely
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnosis of Asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prescription of ICS
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: aGVHD protection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ratio of first stimulus to supramaximal stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amblyopic vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting solicited local adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited general AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained ventricular arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Body Awareness Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in sensory motor processes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline of Pain Severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular Event
Endpoint domain: Mortality/survival
Primary endpoint: Time to Recovery Through Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response rate in over-granulation severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Reactive Oxygen Species (ROS) Generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein Expression of p47phox Subunit of NADPH Oxidase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA Expression of p47phox Subunit of NADPH Oxidase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Borderline Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper airway collapsibility (Vpassive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Gait Velocity During Self-selected Overground Walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Dorsiflexion Angle During Swing Phase of Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural Sway Areas During Quiet Standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving a response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of aortic stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postpartum depression severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Causes of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of influenza-like illness
Endpoint domain: Adverse events/effects
Primary endpoint: number of patients with tumour response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean bone mineral density of the lumbar spine (L2-4 BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal Coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptom Burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Drug Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Any Treatment-emergent Adverse Event (TEAE), Serious AE (SAE), Treatment-related Adverse Event (AE), and Death During the 6-week Treatment Period
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Findings Related to Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in Levels of Anti-thyroid-stimulating Hormone Receptor (Anti-TSHR) Antibodies at Week 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: OPG staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume and Cross-Sectional Area of Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sino-Nasal Outcome Test 22 (SNOT-22)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Early response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehension of benefits/risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin Surface Pressure Under Blood-Draw Tourniquet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sensation during a 1 hour period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston Bowel Preparation Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of Intermediate Phenotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of CD4+CD25+ regulatory T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor specific immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete Response (CR) Rate
Endpoint domain: Mortality/survival
Primary endpoint: change of weight status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: adherence to key quality indicators for antibiotic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Opioid Consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Knowledge assessed by Prostate Cancer Treatment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in 24 Hour Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Pulse Wave Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes